Regencell Bioscience Holdings (RGC) Invested Capital (2020 - 2025)

Regencell Bioscience Holdings has reported Invested Capital for 6 years, with the latest figure at $1.2 million in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital changed N/A year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2025 stood at $1.2 million (changed N/A YoY), and the FY2025 full-year result was $4.9 million, down 40.86% from the prior year.
• Invested Capital for Q4 2025 stood at $1.2 million, down from $4.9 million in the prior quarter.
• The five-year high for Invested Capital was $17.1 million in Q2 2022, with the low at -$3.6 million in Q2 2021.
• Historically, Invested Capital has averaged $6.6 million across 5 years, with a median of $6.5 million in 2024.
• Annual changes were most pronounced in 2021 — Invested Capital slumped 950.96% — and 2022, when it jumped 579.04%.
• Regencell Bioscience Holdings' Invested Capital stood at -$3.6 million in 2021, then jumped by 579.04% to $17.1 million in 2022, then retreated by 29.81% to $12.0 million in 2023, then sank by 31.45% to $8.2 million in 2024, then tumbled by 85.16% to $1.2 million in 2025.
• The last three Invested Capital figures came in at $1.2 million (Q4 2025), $4.9 million (Q2 2025), and $8.2 million (Q2 2024), per Business Quant data.